if they were to buy back 50% of the shares, it will cost them less than $8m at 4 cents per share using company’s fund. why be a shell, when you can be real.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025